These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1173 related items for PubMed ID: 24703882

  • 21. Long non-coding RNA XIST promotes TGF-β-induced epithelial-mesenchymal transition by regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer.
    Li C, Wan L, Liu Z, Xu G, Wang S, Su Z, Zhang Y, Zhang C, Liu X, Lei Z, Zhang HT.
    Cancer Lett; 2018 Apr 01; 418():185-195. PubMed ID: 29339211
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Long Non-Coding RNA RP11-789C1.1 Suppresses Epithelial to Mesenchymal Transition in Gastric Cancer Through the RP11-789C1.1/MiR-5003/E-Cadherin Axis.
    Chen Z, Wu J, Huang W, Peng J, Ye J, Yang L, Yuan Y, Chen C, Zhang C, Cai S, He Y, Wu S, Song W.
    Cell Physiol Biochem; 2018 Apr 01; 47(6):2432-2444. PubMed ID: 29991048
    [Abstract] [Full Text] [Related]

  • 26. Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma.
    Xu S, Yi XM, Tang CP, Ge JP, Zhang ZY, Zhou WQ.
    Oncol Rep; 2016 Jul 01; 36(1):10-22. PubMed ID: 27176634
    [Abstract] [Full Text] [Related]

  • 27. Epithelial to mesenchymal transition is associated with rapamycin resistance.
    Holder AM, Akcakanat A, Adkins F, Evans K, Chen H, Wei C, Milton DR, Li Y, Do KA, Janku F, Meric-Bernstam F.
    Oncotarget; 2015 Aug 14; 6(23):19500-13. PubMed ID: 25944619
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Long non-coding RNA NNT-AS1 promotes cholangiocarcinoma cells proliferation and epithelial-to-mesenchymal transition through down-regulating miR-203.
    Gu Y, Zhu Z, Pei H, Xu D, Jiang Y, Zhang L, Xiao L.
    Aging (Albany NY); 2020 Feb 05; 12(3):2333-2346. PubMed ID: 32019904
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Differential expression of the epithelial mesenchymal transition factors Snail, Slug, Twist, TGF-β, and E-cadherin in ameloblastoma.
    Kurioka K, Wato M, Iseki T, Tanaka A, Morita S.
    Med Mol Morphol; 2017 Jun 05; 50(2):68-75. PubMed ID: 27995335
    [Abstract] [Full Text] [Related]

  • 32. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
    Shao S, Zhao X, Zhang X, Luo M, Zuo X, Huang S, Wang Y, Gu S, Zhao X.
    Mol Cancer; 2015 Feb 03; 14(1):28. PubMed ID: 25645291
    [Abstract] [Full Text] [Related]

  • 33. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5.
    Ye F, Tian L, Zhou Q, Feng D.
    Gene; 2019 Dec 30; 721():144093. PubMed ID: 31473323
    [Abstract] [Full Text] [Related]

  • 34. MicroRNA-16 suppresses epithelial-mesenchymal transition‑related gene expression in human glioma.
    Wang Q, Li X, Zhu Y, Yang P.
    Mol Med Rep; 2014 Dec 30; 10(6):3310-4. PubMed ID: 25242314
    [Abstract] [Full Text] [Related]

  • 35. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.
    Yan LX, Liu YH, Xiang JW, Wu QN, Xu LB, Luo XL, Zhu XL, Liu C, Xu FP, Luo DL, Mei P, Xu J, Zhang KP, Chen J.
    Int J Oncol; 2016 Feb 30; 48(2):471-84. PubMed ID: 26676464
    [Abstract] [Full Text] [Related]

  • 36. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
    Chen QY, Jiao DM, Wu YQ, Chen J, Wang J, Tang XL, Mou H, Hu HZ, Song J, Yan J, Wu LJ, Chen J, Wang Z.
    Oncotarget; 2016 Apr 05; 7(14):18247-61. PubMed ID: 26919096
    [Abstract] [Full Text] [Related]

  • 37. HGF and TGFβ1 differently influenced Wwox regulatory function on Twist program for mesenchymal-epithelial transition in bone metastatic versus parental breast carcinoma cells.
    Bendinelli P, Maroni P, Matteucci E, Desiderio MA.
    Mol Cancer; 2015 Jun 04; 14():112. PubMed ID: 26041563
    [Abstract] [Full Text] [Related]

  • 38. MEG8 long noncoding RNA contributes to epigenetic progression of the epithelial-mesenchymal transition of lung and pancreatic cancer cells.
    Terashima M, Ishimura A, Wanna-Udom S, Suzuki T.
    J Biol Chem; 2018 Nov 23; 293(47):18016-18030. PubMed ID: 30262664
    [Abstract] [Full Text] [Related]

  • 39. LncRNA MEG3 inhibits cell epithelial-mesenchymal transition by sponging miR-421 targeting E-cadherin in breast cancer.
    Zhang W, Shi S, Jiang J, Li X, Lu H, Ren F.
    Biomed Pharmacother; 2017 Jul 23; 91():312-319. PubMed ID: 28463794
    [Abstract] [Full Text] [Related]

  • 40. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.
    Karicheva O, Rodriguez-Vargas JM, Wadier N, Martin-Hernandez K, Vauchelles R, Magroun N, Tissier A, Schreiber V, Dantzer F.
    Oncotarget; 2016 Sep 27; 7(39):64109-64123. PubMed ID: 27579892
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 59.